{"id":194818,"title":"Table 1: Application of this Guidance to API Manufacturing : Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T08:15:57.667000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/table-1-application-guidance-manufacturing-industry.html?wbdisable=true","snippet":"Table 1: Application of this Guidance to API Manufacturing : Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du…","rawSnapshotUrl":"/api/snapshots/raw/194818","browseUrl":"https://replay.healtharchive.ca/job-1/20250419081557/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/table-1-application-guidance-manufacturing-industry.html?wbdisable=true#ha_snapshot=194818","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}